Cargando…
Adoptive cell therapy of triple negative breast cancer with redirected cytokine-induced killer cells
Cytokine-Induced Killer (CIK) cells share several functional and phenotypical properties of both T and natural killer (NK) cells. They represent an attractive approach for cell-based immunotherapy, as they do not require antigen-specific priming for tumor cell recognition, and can be rapidly expande...
Autores principales: | Sommaggio, Roberta, Cappuzzello, Elisa, Dalla Pietà, Anna, Tosi, Anna, Palmerini, Pierangela, Carpanese, Debora, Nicolè, Lorenzo, Rosato, Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7458615/ https://www.ncbi.nlm.nih.gov/pubmed/32923140 http://dx.doi.org/10.1080/2162402X.2020.1777046 |
Ejemplares similares
-
Retargeting cytokine-induced killer cell activity by CD16 engagement with clinical-grade antibodies
por: Cappuzzello, Elisa, et al.
Publicado: (2016) -
Innovative therapeutic strategy for B-cell malignancies that combines obinutuzumab and cytokine-induced killer cells
por: Pietà, Anna Dalla, et al.
Publicado: (2021) -
How can Cytokine-induced killer cells overcome CAR-T cell limits
por: Cappuzzello, Elisa, et al.
Publicado: (2023) -
Identification of a HLA-A*0201-restricted immunogenic epitope from the universal tumor antigen DEPDC1
por: Tosi, Anna, et al.
Publicado: (2017) -
Anti-PSMA CAR-Engineered NK-92 Cells: An Off-the-Shelf Cell Therapy for Prostate Cancer
por: Montagner, Isabella Monia, et al.
Publicado: (2020)